AstraZeneca Group plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (52)

Latest Posts

About This Stock More About This Stock
Bristol-Myers Slips As Citi Says Pfizer Not Interested In Acquisition
Article By: The Fly
Thursday, April 12, 2018 2:07 PM EDT
Shares of Bristol-Myers Squibb are slipping after Citi analyst Andrew Baum said Pfizer's CEO made it clear to him that the latter has no interest in acquiring the company in the absence of transformational data or a de-rating in the stock.
In this article: BMY Also: PFE, AZN, LLY, MRK
Read
E Volatility, Growth And Value Investing
Article By: Maithya Kitonyi
Wednesday, March 7, 2018 7:54 AM EDT
The dynamic nature of the modern financial markets coupled with rising volatility levels has changed the general concept of value investing.
In this article: VIX, AZN, IBM, PFE, AMZN, MSFT, NFLX
Read
2 Large-Cap Drug Stocks Missing Out On Industry Rally In '17
Article By: Zacks Investment Research
Tuesday, November 28, 2017 7:31 PM EDT
Stocks with large market cap have done particularly well. After declining 5.2% last year, the Large Cap Pharma industry has risen 15.3% this year so far with a number of things going in its favor.
In this article: GSK, MRK Also: AZN, JNJ, NVO, NVS, PFE
Read
FDA Approves J&J, Glaxo HIV Drug, Roche Presents Data
Article By: Arpita Dutt
Friday, November 24, 2017 1:53 PM EDT
Pipeline and regulatory updates were the focus this week with the FDA approving the first two-drug HIV treatment in the United States and the European Commission granting approval to Johnson & Johnson’s Tremfya.
In this article: AZN, BMY, MRK, RHHBY, PFE, GSK, JNJ, NVS
Read
BMO Argues For Biogen As Most Logical Takeover Target For Pfizer
Article By: The Fly
Monday, November 13, 2017 2:15 PM EDT
Commenting on "significant market speculation" that Pfizer is preparing to execute a large M&A deal, BMO Capital analyst Alex Arfaei argued that he sees a strong strategic rationale for a merger with Biogen.
In this article: PFE, BIIB Also: BMY, MRK, AZN, LLY
Read

PARTNER HEADLINES

Latest Tweets for $AZN

No tweets yet!